Ledger.Open graph →
SEC Form D · filed March 27, 2017

Twist Bioscience Corp

Offering
$33.2M
Sold
$32.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Keith M. Crandell · San Francisco, CADirectorWilliam M. Banyai · San Francisco, CAExec · DirectorBob M. Ragusa · San Francisco, CADirectorFred M. Craves · San Francisco, CADirectorEmily M. Leproust · San Francisco, CAExec · DirectorSolange M. Glaize · San Francisco, CAExecRob M. Chess · San Francisco, CADirectorBill M. Peck · San Francisco, CAExecPaul M. Conley · San Francisco, CADirectorKirk J. Pulley · PORTLAND, ORExecJoseph M. Niehaus · San Francisco, CADirectorBob Nelson · Frisco, TXDirectorSam Liebman · New York, NYDirectorJoe P. Nemeth · Redwood City, CADirectorMichael J. Fourticq, Senior · Houston, TXExec · DirectorWilliam N. Anderson · Houston, TXExec · DirectorBritton L. Brown · Dallas, TXDirectorPeter H. Huizenga · Oak Brook, ILExecMark G. Hilderbrand · San Francisco, CADirectorBarry D. Reynolds · San Francisco, CADirectorStephen P. Bick · Carlsbad, CAExecLouis A. La Luna · Jamison, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗